Literature DB >> 18604728

TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.

Kakoli Das1, Mohd Feroz Mohd Omar, Chee Wee Ong, Suhaimi Bin Abdul Rashid, Bee Keow Peh, Thomas Choudary Putti, Puay Hoon Tan, Kee Seng Chia, Ming Teh, Nilesh Shah, Richie Soong, Manuel Salto-Tellez.   

Abstract

Formalin fixed and paraffin embedded tissue (FFPE) collections in pathology departments are the largest resource for retrospective biomedical research studies. Based on the literature analysis of FFPE related research, as well as our own technical validation, we present the Translational Research Arrays (TRARESA), a tissue microarray centred, hospital based, translational research conceptual framework for both validation and/or discovery of novel biomarkers. TRARESA incorporates the analysis of protein, DNA and RNA in the same samples, correlating with clinical and pathological parameters from each case, and allowing (a) the confirmation of new biomarkers, disease hypotheses and drug targets, and (b) the postulation of novel hypotheses on disease mechanisms and drug targets based on known biomarkers. While presenting TRARESA, we illustrate the use of such a comprehensive approach. The conceptualisation of the role of FFPE-based studies in translational research allows the utilisation of this commodity, and adds to the hypothesis-generating armamentarium of existing high-throughput technologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604728     DOI: 10.1080/00313020802198101

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  9 in total

1.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

2.  Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.

Authors:  Jonathan Stewart; Jacqueline James; Glenn W McCluggage; Stephen McQuaid; Kenneth Arthur; David Boyle; Paul Mullan; Darragh McArt; Benedict Yan; Gareth Irwin; D Paul Harkin; Lei Zhengdeng; Chee-Wee Ong; Jia Yu; David M Virshup; Manuel Salto-Tellez
Journal:  Mod Pathol       Date:  2014-09-26       Impact factor: 7.842

3.  Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma.

Authors:  Supriya Srivastava; Bhavin Thakkar; Khay Guan Yeoh; Khek Yu Ho; Ming Teh; Richie Soong; Manuel Salto-Tellez
Journal:  Virchows Arch       Date:  2015-03-06       Impact factor: 4.064

4.  Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.

Authors:  Kakoli Das; David Tai Leong; Anurag Gupta; Liang Shen; Thomas Putti; Gary S Stein; Andre J van Wijnen; Manuel Salto-Tellez
Journal:  Eur J Cancer       Date:  2009-07-24       Impact factor: 9.162

5.  Study on protecting effects of baicalin and octreotide on hepatic injury in rats with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Jie Zhang; Zheng Ren; Guang-Hua Feng; Wei Zhu; Yang Cai; Qi-Jun Yang; Tong-Fa Ju; Qi Xie; Wen-Qin Yuan
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

6.  MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.

Authors:  Margaretha van der Deen; Hanna Taipaleenmäki; Ying Zhang; Nadiya M Teplyuk; Anurag Gupta; Senthilkumar Cinghu; Kristen Shogren; Avudaiappan Maran; Michael J Yaszemski; Ling Ling; Simon M Cool; David T Leong; Christian Dierkes; Jozef Zustin; Manuel Salto-Tellez; Yoshiaki Ito; Suk-Chul Bae; Maria Zielenska; Jeremy A Squire; Jane B Lian; Janet L Stein; Gerard P Zambetti; Stephen N Jones; Mario Galindo; Eric Hesse; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

7.  JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.

Authors:  Yi Fang Lee; Lance David Miller; Xiu Bin Chan; Michael A Black; Brendan Pang; Chee Wee Ong; Manuel Salto-Tellez; Edison T Liu; Kartiki V Desai
Journal:  Breast Cancer Res       Date:  2012-05-23       Impact factor: 6.466

8.  Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.

Authors:  Wendy Weijia Soon; Lance David Miller; Michael A Black; Cyril Dalmasso; Xiu Bin Chan; Brendan Pang; Chee Wee Ong; Manuel Salto-Tellez; Kartiki V Desai; Edison T Liu
Journal:  EMBO Mol Med       Date:  2011-06-08       Impact factor: 12.137

9.  A morpho-molecular prognostic model for hepatocellular carcinoma.

Authors:  S Srivastava; K F Wong; C W Ong; C Y Huak; K G Yeoh; M Teh; J M Luk; M Salto-Tellez
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.